Utrilla-Trigo, S.; Jiménez-Cabello, L.; Alonso-Ravelo, R.; Calvo-Pinilla, E.; MarÃn-López, A.; Moreno, S.; Lorenzo, G.; Benavides, J.; Gilbert, S.; Nogales, A.;
et al. Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines 2020, 8, 346.
https://doi.org/10.3390/vaccines8030346
AMA Style
Utrilla-Trigo S, Jiménez-Cabello L, Alonso-Ravelo R, Calvo-Pinilla E, MarÃn-López A, Moreno S, Lorenzo G, Benavides J, Gilbert S, Nogales A,
et al. Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines. 2020; 8(3):346.
https://doi.org/10.3390/vaccines8030346
Chicago/Turabian Style
Utrilla-Trigo, Sergio, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, Eva Calvo-Pinilla, Alejandro MarÃn-López, Sandra Moreno, Gema Lorenzo, Julio Benavides, Sarah Gilbert, Aitor Nogales,
and et al. 2020. "Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus" Vaccines 8, no. 3: 346.
https://doi.org/10.3390/vaccines8030346
APA Style
Utrilla-Trigo, S., Jiménez-Cabello, L., Alonso-Ravelo, R., Calvo-Pinilla, E., MarÃn-López, A., Moreno, S., Lorenzo, G., Benavides, J., Gilbert, S., Nogales, A., & Ortego, J.
(2020). Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines, 8(3), 346.
https://doi.org/10.3390/vaccines8030346